Abstract
Acute and chronic urinary tract obstruction (UTO) are important causes of AKI and CKD globally, and the vast majority of such patients are managed by non-renal physicians and urologists. However, there is an important role for nephrologists in the management of AKI or CKD associated with acquired UTO, and an integrated multidisciplinary pathway for complex or sick patients is worth establishing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nitti V. Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol. 2005;7 Suppl 6:S14–21.
Abrams P. The diagnosis of bladder outlet obstruction: urodynamics. In: Cockett ATK, Khoury S, Aso Y, editors. Proceedings, the 3rd international consultation on BPH. Geneva: World Health Organization; 1995. p. 299–367.
Renjen P, Bellah R, Hellinger JC, Darge K. Advances in uroradiologic imaging in children. Radiol Clin North Am. 2012;50:207–18.
Perez-Brayfield MR. A prospective study comparing ultrasound, nuclear scintigraphy and dynamic contrast enhanced magnetic resonance imaging in the evaluation of hydronephrosis. J Urol. 2003;170:1330–4.
Grattan-Smith JD. MR urography anatomy and physiology. Pediatr Radiol. 2008;38 Suppl 2:S275–80.
Veenboer PW, de Jong TPVM. Antegrade pressure measurement as a diagnostic tool in modern pediatric urology. World J Urol. 2011;29:737–45.
Lupton EW, George NJ. The APR: 35 years on. BJU Int. 2010;105(1):94–100.
Parsons BA, Hashim H. Emerging treatment options for benign prostatic obstruction. Curr Urol Rep. 2011;12:247–54.
Uppot R. Emergent nephrostomy tube placement for acute urinary obstruction. Tech Vasc Interv Radiol. 2009;12:154–61.
Adamo R, Saad WEA, Brown DB. Percutaneous ureteral interventions. Tech Vasc Interv Radiol. 2009;12:205–15.
Uibu T, Oksa P, Auvinen A, Honkanen E, Metsarinne K, Saha H, et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet. 2004;363:1422–6.
Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. 2009;33:1833–9.
Wen D. Takayasu arteritis: diagnosis, treatment and prognosis. Int Rev Immunol. 2012;31:462–73.
Magrey MN, Husni ME, Kushner I, et al. Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum. 2009;61:674–9.
Wong LM, Cleeve LK, Milner AD, Pitman AG. Malignant ureteral obstruction: outcomes after intervention. Have things changed?. J Urol. 2007;178(1):178–83.
Sountoulides P, Kaplan A, Kaufmann OG, Sofikitis N. Current status for use of metal stents in the management of malignant ureteric obstruction. BJU Int. 2010;105:1066–72.
Woodhouse C. Supra-vesical urinary diversion and ureteric re-implantation for malignant disease. Clin Oncol. 2011;22:727–32.
Kouba E, Wallen EM, Pruthi RS. Management of urethral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes. J Urol. 2008;180:444–50.
Liberman D, McCormack M. Renal and urologic problems: management of ureteric obstruction. Curr Opin Support Palliat Care. 2012;6:316–21.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Smith, G., Harber, M. (2014). Acquired Urinary Tract Obstruction. In: Harber, M. (eds) Practical Nephrology. Springer, London. https://doi.org/10.1007/978-1-4471-5547-8_38
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5547-8_38
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5546-1
Online ISBN: 978-1-4471-5547-8
eBook Packages: MedicineMedicine (R0)